🇺🇸

US SEC Filing Intelligence

· daily

US Activist Hedge Fund Institutional SEC 13D 13G — August 24, 2026

This intelligence stream covers 40 filings (33 new, 7 for context) focused on major shareholder positions and activist activity. Key themes include a surge in activist campaigns targeting strategic reviews (CVRx, GEE Group), significant insider sales and ownership reductions (Tencent in Amer Sports, D.E. Shaw in Gossamer Bio, Fresenius KGaA in Fresenius Medical Care), and major M&A-related ownership changes (Lhoist/LNA Holding in Martin Marietta, Star Equity in Harte Hanks). Period-over-period data reveals notable insider buying at discounted prices (Chernett in CVRx, Levine in Global Water Resources) and a significant increase in a passive stake (Kite Lake in Optimum Communications) driven by a tender offer. The most critical development is the activist push at CVRx, where a 5.5% holder is demanding a sale, and the $7B Martin Marietta/Lhoist deal creating a new 15.4% shareholder with governance rights. Portfolio-level patterns show capital flowing into value/small-cap situations and a divergence between activist demands for change and passive stake increases post-corporate events.

23 high priority 17 medium 40 total filings
· daily

S&P 500 Financials Sector SEC Filings — August 24, 2026

The 10 filings for the S&P 500 Financials stream reveal a sector dominated by insider share disposals, primarily through tax-withholding and 10b5-1 plan sales, which skews sentiment neutral-to-negative but does not signal broad management distress. Coinbase Global accounts for 5 of the 10 filings, showing a pattern of senior executives (CFO, COO, CAO) and directors converting equity awards and having shares withheld for taxes, a routine but high-volume event that suggests a significant vesting period. VISA stands out with two high-profile insider sales: the CEO sold $2.16M and the President of Technology sold $6.65M, both under 10b5-1 plans, which may indicate a pre-planned diversification strategy rather than a bearish outlook. The only non-insider transaction is a 10% owner (Japan Post Holdings) selling a small portion of its massive AFLAC stake, a negligible move. No period-over-period comparisons, forward-looking guidance, or capital allocation changes were present in the enriched data, limiting trend analysis. The key takeaway is a sector-wide liquidity event for insiders, with VISA's CEO sale being the most material signal for investors to monitor for any change in corporate narrative.

5 high priority 5 medium 10 total filings
· daily

S&P 500 Energy Sector SEC Filings — August 24, 2026

The four filings from the S&P 500 Energy sector reveal a mixed but cautious insider sentiment, with no material period-over-period financial trends or forward-looking guidance changes to analyze. The most significant signal is a substantial insider sale by ConocoPhillips' Senior Vice President, totaling ~$1.28M, which flags potential concern at the executive level. In contrast, two smaller insider gifts at Targa Resources and Valero Energy are routine and carry no actionable signal, while a token purchase by a 10% owner at Texas Pacific Land Corp is negligible in size. The lack of any period-over-period comparisons, capital allocation changes, or forward-looking statements across these filings limits the depth of portfolio-level trend analysis, but the insider activity pattern—one large sale versus no significant buys—suggests a cautious stance among energy executives. The sector appears to be in a wait-and-see mode, with no major catalysts or red flags emerging from this batch of filings.

4 high priority 4 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — August 24, 2026

The S&P 500 Consumer Staples sector is exhibiting a pronounced wave of insider selling, particularly concentrated at Procter & Gamble, where nine senior executives—including the Chairman, CEO, CFO, and multiple business unit heads—collectively sold over $3.9 million in stock within a single trading day. This coordinated selling at a uniform price of ~$143.79 suggests a pre-arranged plan but raises questions about management's conviction at current valuation levels. Concurrently, a 10% owner of Hershey executed sales under a 10b5-1 plan, and Coca-Cola's VP sold $3.76M following option exercises. On the corporate development front, Philip Morris entered a contract manufacturing arrangement with Altria for combustible cigarettes, signaling potential supply chain integration, while Hormel Foods appointed a new CFO from Tyson Foods with a substantial compensation package. The overall sentiment from insider activity is bearish, with no bullish signals detected across the filings. The lack of period-over-period financial comparisons or forward guidance in these filings limits the ability to identify broader sector trends, making the insider selling pattern the most actionable intelligence for the period.

17 high priority 1 medium 18 total filings
· daily

S&P 500 Industrials Sector SEC Filings — August 24, 2026

The 12 filings from the S&P 500 Industrials stream are dominated by a single, significant insider buying event at Republic Services, where a 10% owner invested approximately $40 million, signaling strong conviction in the waste management sector. The remaining 11 filings are routine director equity awards at Norfolk Southern, which, while not market-moving individually, collectively confirm standard governance practices and director alignment. The key takeaway is a stark divergence in insider activity: a major capital deployment in the defensive, cash-flow-rich waste sector versus routine compensation in the cyclical railroad sector. This suggests a potential capital rotation theme within Industrials, favoring stable, asset-light business models with pricing power over those more exposed to volume-sensitive freight demand. The lack of any forward-looking guidance, earnings reports, or material transaction details in these filings limits the ability to identify broad sector trends, making the Republic Services insider purchase the single most actionable data point for the period.

12 high priority 12 total filings
· daily

Contract Option Exercises — August 24, 2026

The two contracts analyzed total $239,740,078 in obligations, with one defense-related (NASA, civilian) and one civilian (NASA) contract, indicating a 1/2 defense-related split. The dominant theme is NASA's continued investment in aerospace testing and space R&D, with Amentum Technology's $239.3M cost-plus-fixed-fee contract for facilities operations at Ames Research Center representing the bulk of the value, though its performance period ended in 2022, limiting forward-looking impact. Lockheed Martin's $424K sole-source R&D contract signals stable, low-risk demand but is immaterial to its revenue. The highest-conviction signal is the low pricing risk across both contracts due to cost-plus-fixed-fee structures, while the key risk is the potential lack of follow-on contracts for Amentum, given the contract's near-completion status.

2 total filings
· daily

Insider Trading Pulse — August 24, 2026

Today's insider trading digest reveals a bifurcated market: significant insider buying at Alibaba (CEO $4.98M) and several smaller-cap names signals confidence, while notable insider selling at Packaging Corp of America ($3.01M), Procter & Gamble (multiple executives), and First Community Corp ($270K) suggests caution. The most prominent pattern is tax-related share withholding across multiple companies (NIQ Global, LiveRamp, GDEV), which is largely neutral but reduces float. Director and CEO purchases at TTM Technologies ($525K), Insulet ($162K), and Sensus Healthcare ($60.5K) are positive signals. No major period-over-period financial trends or guidance changes were disclosed in these filings, but the concentration of insider buying in tech and healthcare contrasts with selling in consumer staples and financials. The overall sentiment is mixed, with 13 positive, 13 negative, and 24 neutral filings.

50 high priority 50 total filings
· daily

Mega Contracts Monitor ($100M+) — August 24, 2026

This single-contract digest covers a $239.3M NASA award to Amentum Technology, Inc. for aerospace testing and facilities operations at Ames Research Center, with zero defense-related content. The contract is a cost-plus-fixed-fee arrangement that ended in August 2022, making it largely backward-looking and of limited forward investment relevance. The neutral signal strength (5/10) and low materiality (4/10) reflect the contract's age and near-completion status. Key watch items include any follow-on recompete for ATOM-4 services and Amentum's ability to sustain NASA facilities support revenue. No bullish or bearish signals are triggered from this data alone.

1 total filings
· daily

Dow Jones 30 Stocks SEC Filings — August 24, 2026

The 28 filings from Dow 30 constituents reveal a pronounced wave of insider selling concentrated in Procter & Gamble and Coca-Cola, with 13 separate transactions from P&G executives and a $3.76M sale by a Coke executive, signaling potential caution at the top of these consumer staples giants. In contrast, Salesforce directors uniformly exercised and converted restricted stock units (441 shares each) with no open-market sales, indicating routine compensation management rather than bearish conviction. Visa saw its CEO and President of Technology execute large 10b5-1 plan sales totaling $8.8M, which are pre-planned but still notable in magnitude. The absence of any forward-looking guidance, capital allocation changes, or period-over-period financial comparisons in these filings limits trend analysis, but the sheer density of insider selling—especially across multiple C-suite officers at P&G—creates a bearish signal for the consumer staples sector. No M&A, dividend, or buyback activity was reported in this batch, making insider transactions the dominant actionable data point. The lack of positive insider buying or upward guidance revisions leaves the digest tilted toward caution, with Salesforce's routine RSU conversions as the only neutral-to-slightly-positive signal.

28 high priority 28 total filings
· daily

High-Value Federal Grants ($5M+) — August 24, 2026

This digest covers a single high-value federal grant: a $239.3M cost-plus-fixed-fee contract awarded to Amentum Technology, Inc. by NASA Ames Research Center for aerospace testing and facilities operations. The contract is entirely civilian (0% defense-related) and represents stable, recurring infrastructure support revenue. However, with a performance period ending in August 2022, this award is largely historical and offers limited forward-looking investment signals. The key takeaway is the lack of new contract momentum in this period, with the highest-conviction signal being a neutral assessment of Amentum’s legacy revenue stream. A primary risk is the absence of a follow-on or recompete opportunity, which could leave a revenue gap for Amentum.

1 total filings
· daily

General Federal Contracts — August 24, 2026

The sole contract in this digest is a $239.3 million cost-plus-fixed-fee award from NASA Ames Research Center to Amentum Technology, Inc. for aerospace testing and facilities operations, representing a fully civilian (non-defense) obligation. The contract's performance period (2016-2022) has ended, and with $120 million already outlaid, the revenue is largely realized, limiting forward-looking investment implications. The highest-conviction signal is the low pricing risk due to the cost-plus structure, which ensures predictable margins for Amentum, but the contract's age and near-completion reduce its materiality. Key watch items include any recompete for the ATOM-4 services at NASA Ames and shifts in NASA's facilities outsourcing strategy.

1 total filings
· daily

All NASA Contracts — August 24, 2026

The sole NASA contract analyzed, a $239.3M cost-plus-fixed-fee award to Amentum Technology, Inc. for facilities operations at Ames Research Center, is a legacy award (2016-2022) with no forward-looking investment catalyst. As a fully civilian, competed contract now near completion, it provides no actionable signal for defense sector exposure or near-term revenue growth. The neutral signal (5/10 strength, 4/10 materiality) and absence of any bullish or bearish signals underscore the digest's limited utility for portfolio decisions. Key risk is the lack of a recompete trigger, making this a non-event for institutional investors focused on current procurement trends.

1 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — August 24, 2026

This intelligence stream covers four US-listed companies facing severe corporate distress, including three new delisting/receivership events and one ongoing filing delinquency. The filings reveal a cluster of micro-cap companies (Senmiao Technology, Northann Corp., Bubblr Inc.) facing terminal liquidity crises, with negative equity, trading suspensions, and court-ordered receivership. Hub Group, a larger logistics firm, represents a different distress pattern: repeated filing delinquencies without immediate trading impact, suggesting internal control failures rather than insolvency. The most critical development is Bubblr Inc.'s court-appointed receivership (Materiality 10/10), which effectively transfers corporate control to a court officer. Across all filings, period-over-period data is sparse, but the absence of positive financial trends is notable—Senmiao's negative equity of -$35.3 million and Northann's multi-section NYSE American violations indicate systemic governance failures. No insider trading activity, capital allocation actions, or forward guidance were disclosed in any filing, which is itself a bearish signal for transparency. The overarching theme is a wave of micro-cap delistings concentrated in the same week (August 18-21, 2026), likely triggered by accelerated regulatory enforcement and deteriorating balance sheets. Investors should expect heightened volatility in these names as OTC trading begins and legal proceedings unfold.

4 high priority 4 total filings
· daily

Global High-Priority Regulatory Events — August 24, 2026

This digest of 34 filings for August 24, 2026, reveals a pronounced bifurcation in corporate health: a cluster of distressed entities facing regulatory insolvency or delisting, while others execute strategic transactions like M&A and open offers. A primary theme is the wave of Nasdaq/NYSE American delisting actions targeting SPACs (Pantages Capital, Senmiao Technology, Northann Corp) and growth companies, signaling tighter exchange scrutiny amid market volatility. Conversely, mid-cap acquisitions and divestitures are prevalent, particularly in Indian industrials (Pavna Industries, Majestic Auto, HEG Limited), with buyers focusing on core businesses and unlocking value. The complete liquidation of the Hashdex Bitcoin ETF (DEFI) and the court-appointed receivership of Bubblr Inc. represent the two most extreme downside events, highlighting total capital loss scenarios. Capital allocation trends are defensive, with companies both cutting complexity (Pavna, Almondz Global) and seeking strategic growth (Martin Marietta, Blue Cloud Softech). Insider activity is minimal across filings, but management changes in HEG and Integrated Wellness signal strategic pivots. Overall, the period underscores a 'survival of the fittest' environment where regulatory compliance, strategic focus, and financial fortitude are paramount.

34 high priority 34 total filings
· daily

US SEC Filings Daily Market Digest — August 24, 2026

The August 24, 2026, filing stream reveals a market dominated by significant capital allocation events, strategic shifts, and mixed legal outcomes. Key themes include a wave of insider buying at Alibaba Group, signaling management confidence despite a major equity placement, and a notable 'going private' transaction for Utz Brands at a 91% premium. The SPAC sector shows continued stress, with YHN Acquisition I facing shareholder skepticism and Roman DBDR Acquisition Corp. II receiving a Nasdaq deficiency notice. Legal and regulatory developments are prominent, with mixed verdicts for Cytek Biosciences and Sable Offshore Corp. creating binary risk/reward scenarios. The energy and materials sector sees strategic divestitures, like Comstock Inc. selling its mining assets, while healthcare shows early-stage clinical progress from Precision BioSciences and Tiziana Life Sciences. Overall, the data points to a market where companies are actively managing their capital structures and legal exposures, with insider activity providing a clear signal of management conviction at Alibaba.

19 high priority 31 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — August 24, 2026

Today's filing stream is dominated by a coordinated wave of insider selling at DoorDash, with six executives (including the CFO, COO, and multiple directors) unloading stock at ~$220-$225 per share over the same period, totaling over $29M in disclosed sales. This pattern, including a $16.3M sale by Director Stanley Tang, signals concentrated management conviction to reduce exposure at current levels, despite some sales being under Rule 10b5-1 plans. Outside of DoorDash, Yum! Brands' COO sold nearly 99% of their holdings in a single transaction, a severe risk flag. Chipotle's filing was unreadable and offers no actionable data. The overall sector theme is a glaring disconnect between insider selling and consumer spending narratives, presenting a bearish tactical signal for these specific names, especially DoorDash. Portfolio-level trends from period comparisons are absent in this batch, but the aggregate insider activity demands immediate attention.

9 high priority 9 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — August 24, 2026

The six filings from the S&P 500 Healthcare stream for August 24, 2026, are dominated by insider trading activity, revealing a stark divergence in management sentiment. The most critical signal is a massive, nearly complete divestiture by Danaher's CEO, who sold over $8.5 million in stock, reducing his personal stake to near zero—a highly bearish red flag. In contrast, Thermo Fisher's CEO executed a large option exercise and modest sale under a 10b5-1 plan, suggesting a more structured, less alarming approach. The remaining filings (Becton Dickinson, IDEXX, Medtronic) are routine tax-withholding transactions, carrying neutral sentiment. No period-over-period financial comparisons, forward-looking guidance, or capital allocation data were present in these filings, limiting the ability to identify portfolio-level revenue or margin trends. The overarching theme is a concentrated insider risk at Danaher, which overshadows the otherwise routine nature of the other filings.

6 high priority 6 total filings
· daily

US Earnings Financial Results SEC Filings — August 24, 2026

The eight filings reveal a market bifurcated between a few pockets of operational strength and a broader trend of restructuring, cash burn, and margin pressure. ConnectM Technology Solutions and Selectis Health both posted headline net income turnarounds, but these were entirely driven by non-recurring gains from discontinued operations and asset sales, masking underlying operational cash burn and revenue declines. Bio-Techne and Bridgford Foods represent two sides of a stagnant-growth coin: Bio-Techne’s flat sales and margin compression are being addressed via a major divestiture, while Bridgford’s deepening losses and rising leverage signal distress. Napco Security Technologies stands out as a genuine growth story with strong 11.4% revenue growth and expanding gross margins, though a one-time litigation charge depressed net income. The three smallest entities—Samos Energy (a pre-revenue SPAC) and Natics Corp.—remain in pre-revenue or micro-cap survival mode, offering no operational comparables. The dominant portfolio-level theme is the reliance on non-operational gains to mask underlying business deterioration, with 3 of 8 companies reporting net income driven by asset sales or discontinued operations. Insider trading data was notably absent across all filings, removing a key conviction signal. The forward-looking data is sparse, with only Bio-Techne providing clear guidance on its divestiture timeline, creating a catalyst calendar that is heavily weighted toward restructuring events rather than organic growth milestones. Capital allocation patterns are defensive: Bio-Techne is pruning assets, Bridgford is drawing on credit lines, and the SPACs are burning cash on formation costs. The actionable intelligence centers on Napco’s organic momentum versus the rest, and the risk of accounting-driven 'turnarounds' at ConnectM and Selectis Health that lack cash flow confirmation. Scheduled events are limited, but Bio-Techne’s pending sale of its Diagnostics and Spatial Biology segment is the most material catalyst on the horizon. Overall, the digest suggests a cautious stance on companies relying on one-time gains and a selective opportunity in Napco’s recurring service revenue growth. No filings were excluded as all eight fall within the broad market scope of the 'Financial Results & Earnings' stream.

8 high priority 8 total filings
· daily

US Executive Compensation Proxy SEC Filings — August 24, 2026

The 13 enriched proxy filings for August 2026 reveal a pronounced wave of corporate distress and restructuring actions, with 6 of the 13 companies disclosing reverse stock splits and 4 SPACs/blank-check entities seeking yet another deadline extension, signaling a severe capital market bottleneck for micro-cap and troubled issuers. Period-over-period data, though sparse in these non-financial proxy statements, is inferred from insider activity and transaction data: exceptionally high dilution is projected at Adial Pharmaceuticals (legacy holders to own just 7.7% post-merger) and NEXGEL (mandated 6x share increase due to convertible note overhang), while Apollo Commercial Real Estate's liquidation plan provides a positive floor for distribution estimates ($7.75–$8.50 per share). Insider sentiment is markedly mixed, with LogicMark’s Special Committee receiving a fairness opinion showing negative equity values, yet no major insider sales are flagged, suggesting a wait-and-see approach. Forward-looking data builds a busy catalyst calendar through October and November 2026, with nine special or annual meetings concentrated in those months, and a key deadline of October 19 for NEXGEL to regain Nasdaq compliance. The overarching theme is a capital structure stress test, where equity holders are being asked to approve dilution, liquidation, or extension, with little evidence of organic growth from period-over-period comparisons.

13 high priority 13 total filings
· daily

US IPO Pipeline SEC S-1 Filings — August 24, 2026

The August 24, 2026 IPO pipeline is dominated by two blank-check companies (Essential Minerals Acquisition Corp and Live Oak Acquisition Corp. VI) seeking a combined $350 million, alongside three resale registrations from cash-strapped issuers (NEXTNRG, Polar Power, and Serina Therapeutics) and one de-SPAC merger filing (OHB Pediatrics Ltd.). A critical portfolio-level pattern is the extreme financial distress among operating companies: NEXTNRG has only ~$4.5M cash (funding through Dec 1, 2026) and negative working capital, while Polar Power reports just ~$0.1M in stockholders' equity against a Nasdaq minimum of $2.5M. The blank-check IPOs offer a stark contrast with zero-operating-risk structures but carry significant dilution risks for public shareholders. No period-over-period comparisons were available as all filings are initial registrations without historical financial performance data. The most actionable insight is the imminent liquidity crisis at NEXTNRG and Polar Power, which could force distressed asset sales or reverse stock splits, creating potential short-term trading opportunities.

6 high priority 6 total filings